The CaSR Modulator NPS-2143 Reduced UV-Induced DNA Damage in Skh:hr1 Hairless Mice but Minimally Inhibited Skin Tumours
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24054921 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Chen Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Sciences and Bosch Institute, University of Sydney, Sydney, NSW 2006, Australia. Hauptthemen laut MEDLINE: Receptors, Calcium-Sensing, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
The calcium-sensing receptor (CaSR) is an important regulator of epidermal function. We previously reported that knockdown of the CaSR or treatment with its negative allosteric modulator, NPS-2143, significantly reduced UV-induced DNA damage, a key factor in skin cancer development. We subsequently wanted to test whether topical NPS-2143 could also reduce UV-DNA damage, immune suppression, or skin tumour development in mice. In this study, topical application of NPS-2143 (228 or 2280 pmol/cm2) to Skh:hr1 female mice reduced UV-induced cyclobutane pyrimidine dimers (CPD) (p < 0.05) and oxidative DNA damage (8-OHdG) (p < 0.05) to a similar extent as the known photoprotective agent 1,25(OH)2 vitamin D3 (calcitriol, 1,25D). Topical NPS-2143 failed to rescue UV-induced immunosuppression in a contact hypersensitivity study. In a chronic UV photocarcinogenesis protocol, topical NPS-2143 reduced squamous cell carcinomas for only up to 24 weeks (p < 0.02) but had no other effect on skin tumour development. In human keratinocytes, 1,25D, which protected mice from UV-induced skin tumours, significantly reduced UV-upregulated p-CREB expression (p < 0.01), a potential early anti-tumour marker, while NPS-2143 had no effect. This result, together with the failure to reduce UV-induced immunosuppression, may explain why the reduction in UV-DNA damage in mice with NPS-2143 was not sufficient to inhibit skin tumour formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Sciences and Bosch Institute, University of Sydney, Sydney, NSW 2006, Australia.
- School of Chemical Engineering, University of New South Wales, Sydney, NSW 2033, Australia.
- Sydney Informatics Hub, University of Sydney, Sydney, NSW 2008, Australia.
- Douglas Cohen Department of Paediatric Surgery, The Children's Hospital at Westmead Clinical School, The Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2145, Australia.
- School of Life and Environmental Sciences, Charles Perkins Centre (D17), University of Sydney, Sydney, NSW 2006, Australia.
ORCID-Profile: Mark Stephen Rybchyn, Andrew J A Holland, Rebecca Sara Mason
Förderung
- National Health and Medical Research Council
Zitieren
APA
Yang, C., Rybchyn, M. S., De Silva, W. G. M., Matthews, J., Dixon, K. M., Holland, A. J. A., Conigrave, A. D., & Mason, R. S. (2023). The CaSR Modulator NPS-2143 Reduced UV-Induced DNA Damage in Skh:hr1 Hairless Mice but Minimally Inhibited Skin Tumours. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054921
Vancouver
Yang C, Rybchyn MS, De Silva WGM, Matthews J, Dixon KM, Holland AJA, et al. The CaSR Modulator NPS-2143 Reduced UV-Induced DNA Damage in Skh:hr1 Hairless Mice but Minimally Inhibited Skin Tumours. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054921
BibTeX
@article{Yang2023,
author = {Yang, Chen and Rybchyn, Mark Stephen and De Silva, Warusavithana Gunawardena Manori and Matthews, Jim and Dixon, Katie Marie and Holland, Andrew J A and Conigrave, Arthur David and Mason, Rebecca Sara},
title = {The CaSR Modulator NPS-2143 Reduced UV-Induced DNA Damage in Skh:hr1 Hairless Mice but Minimally Inhibited Skin Tumours},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24054921}
}
EUVIMED